Cargando…

FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells

Cancer initiating cells (CICs) drive tumor formation and drug-resistance, but how they develop drug-resistance characteristics is not well understood. In this study, we demonstrate that chemotherapeutic agent FOLFOX, commonly used for drug-resistant/metastatic colorectal cancer (CRC) treatment, indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghatak, Shibnath, Hascall, Vincent C., Markwald, Roger R., Misra, Suniti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828641/ https://www.ncbi.nlm.nih.gov/pubmed/33451103 http://dx.doi.org/10.3390/ijms22020753

Ejemplares similares

Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)

Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)

Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
por: Misra, Suniti, et al.
Publicado: (2015)

Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor
por: Ghatak, Shibnath, et al.
Publicado: (2010)

Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery
por: Misra, Suniti, et al.
Publicado: (2015)

Periostin/Filamin-A: A Candidate Central Regulatory Axis for Valve Fibrogenesis and Matrix Compaction
por: Misra, Suniti, et al.
Publicado: (2021)

Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis
por: Ghatak, Shibnath, et al.
Publicado: (2015)

A Case of Acute Encephalopathy After the Initiation of FOLFOX Chemotherapy in a Patient With Colon Cancer
por: Kim, Jin S, et al.
Publicado: (2023)

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer
por: Jeon, Hyeong-Joon, et al.
Publicado: (2011)

Prevotella contributes to individual response of FOLFOX in colon cancer
por: Hou, Xiao‐Ying, et al.
Publicado: (2021)

Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
por: Hou, Xiaoying, et al.
Publicado: (2021)

CD44variant exon 9 plays an important role in colon cancer initiating cells
por: Kimura, Youhei, et al.
Publicado: (2013)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

CD44 and Helicobacter pylori-related colon oncogenesis
por: Kountouras, Jannis, et al.
Publicado: (2015)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021)

Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44(-/-) tumor cells, MEFs and macrophages
por: Schultz, Kristin, et al.
Publicado: (2018)

Investigation of neutron-deficient isotopes $^{160}$Yb, $^{161}$Yb, $^{163}$Yb and $^{165}$Yb
por: Adam, J, et al.
Publicado: (1976)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis
por: Chu, Qiaoqiao, et al.
Publicado: (2016)

Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer
por: Salmi, Narimane, et al.
Publicado: (2014)

Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?
por: Tsai, Yi-Jian, et al.
Publicado: (2016)

Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
por: Murray, Nigel P, et al.
Publicado: (2019)

Commentary: Intermittent Fasting and Akkermansia Muciniphila Potentiate the Antitumor Efficacy of FOLFOX in Colon Cancer
por: Su, Junhong, et al.
Publicado: (2022)

CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion
por: Le Bras, Grégoire F., et al.
Publicado: (2011)

Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway
por: Wang, Jin-Zhu, et al.
Publicado: (2022)

PDGF Suppresses the Sulfation of CD44v and Potentiates CD44v-Mediated Binding of Colon Carcinoma Cells to Fibrin under Flow
por: Alves, Christina S., et al.
Publicado: (2012)

Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop
por: Walter, Romina J., et al.
Publicado: (2022)

Sustained Improvement in a Metastatic Colon Cancer Patient with FOLFIRI-Aflibercept after FOLFOX Failure
por: Aggarwal, Shyam
Publicado: (2015)

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report
por: Zichi, Clizia, et al.
Publicado: (2018)

Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer
por: Huang, Wen-Yen, et al.
Publicado: (2017)

Clinical Significance of has_circ_0055625 in Colon Cancer Patients Undergoing FOLFOX Chemotherapy Treatment
por: Liu, Xiuhua, et al.
Publicado: (2021)

CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells
por: Zöller, Margot
Publicado: (2015)

Distributive Nd-to-Yb Energy Transfer within Pure [YbNdYb] Heterometallic Molecules
por: Maniaki, Diamantoula, et al.
Publicado: (2023)

Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer
por: Du, Wenjing, et al.
Publicado: (2018)

CD44 cross-linking increases malignancy of breast cancer via upregulation of p-Moesin
por: Hu, Song, et al.
Publicado: (2020)

Activation of the mTOR pathway promotes neurite growth through upregulation of CD44 expression
por: Zhang, Jiwei, et al.
Publicado: (2023)

(89)Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells
por: Park, Jin Won, et al.
Publicado: (2021)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vdjvrt1qtbhii02711j81ipukj